Active implantable medical devices such as cardiac pacemaker systems, cochlear implants, implantable infusion pumps, cardiac resynchronization therapy devices aid in improving patient’s health and outcome of the medical treatment. Active implantable medical devices are prosthetic devices, which provide support in functioning of organs. For instance, pacemakers and defibrillators are capable of monitoring the heart rhythm. Pacemakers replace the natural pacemaker of the heart i.e. sinoatrial node (SA node) and defibrillator, monitors the heart rhythm and can prevent cardiac arrest. These devices come under Class II and some under Class III devices in the U.S. FDA medical devices listing and are subject to stringent regulations as they pose surgical risks during placement, bruising at surgical site, pain, and high risks due to implant failure. The active implantable medical devices market is dominated by few leading players such as Medtronic Plc., Abbott Laboratories, Boston Scientific Corporation, and Cochlear Ltd. accounting for over 70% of the market share.
Market Dynamics
Advancements in technology such as magnetic resonance imaging (MRI) compatible pacemakers and growing support in favor of use of such devices in cardiovascular and chronic pain diseases is expected to boost growth of the active implantable medical devices market. For instance, in November 2017, American Heart Association (AHA), the American College of Cardiology (ACC), and the Heart Rhythm Society (HRS) approved the use of subcutaneous implantable cardioverter defibrillator, (S-ICD), for the treatment of ventricular arrhythmias and to prevent cardiac arrest. Major manufacturers in the market are focusing on collaborations and mergers and acquisitions and are increasingly investing in research and development of implantable devices. For instance, merger of Sorin Group and Cyberonics to form LivaNova Plc in 2015. Furthermore, effectiveness of these devices in improving medical outcomes of cardiovascular and chronic pain diseases, absence of effective alternatives to these devices and continuous product launches is expected to fuel growth of the market.
Key features of the study:
- This report provides in-depth analysis of active implantable medical devices market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2016 as the base year
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
- It profiles leading players in the global active implantable medical devices market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
- Key companies covered as a part of this study include Cochlear Limited, Boston Scientific Corporation, Medtronic Plc, LivaNova Plc, Abbott laboratories, Sonova Holding AG, William Demant holding A/S, Nurotron Biotechnology Co., Ltd., and Med-EL
- Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
- The global active implantable medical devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision making through the various strategy matrices used in analyzing the active implantable medical devices market
Detailed Segmentation:
- Global Active Implantable Medical Devices Market, By Product Type:
- Pacemakers
- Implantable Cardioverter Defibrillators (ICD)
- Cardiac Resynchronization Therapy Devices (CRT-D)
- Neurostimulators
- Drug Infusion Pumps
- Implantable Loop Recorders
- Cochlear Implants
- Others
- Global Active Implantable Medical Devices Market, By Geography:
- North America
- By Product Type:
- Pacemakers
- Implantable Cardioverter Defibrillators (ICD)
- Cardiac Resynchronization Therapy Devices (CRT-D)
- Neurostimulators
- Drug Infusion Pumps
- Implantable Loop Recorders
- Cochlear Implants
- Others
- By Country:
- Europe
- By Product Type:
- Pacemakers
- Implantable Cardioverter Defibrillators (ICD)
- Cardiac Resynchronization Therapy Devices (CRT-D)
- Neurostimulators
- Drug Infusion Pumps
- Implantable Loop Recorders
- Cochlear Implants
- Others
- By Country:
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Product Type:
- Pacemakers
- Implantable Cardioverter Defibrillators (ICD)
- Cardiac Resynchronization Therapy Devices (CRT-D)
- Neurostimulators
- Drug Infusion Pumps
- Implantable Loop Recorders
- Cochlear Implants
- Others
- By Country:
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- By Product Type:
- Pacemakers
- Implantable Cardioverter Defibrillators (ICD)
- Cardiac Resynchronization Therapy Devices (CRT-D)
- Neurostimulators
- Drug Infusion Pumps
- Implantable Loop Recorders
- Cochlear Implants
- Others
- By Country:
- Brazil
- Mexico
- Rest of Latin America
- Middle East
- By Product Type:
- Pacemakers
- Implantable Cardioverter Defibrillators (ICD)
- Cardiac Resynchronization Therapy Devices (CRT-D)
- Neurostimulators
- Drug Infusion Pumps
- Implantable Loop Recorders
- Cochlear Implants
- Others
- By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
- By Product Type:
- Pacemakers
- Implantable Cardioverter Defibrillators (ICD)
- Cardiac Resynchronization Therapy Devices (CRT-D)
- Neurostimulators
- Drug Infusion Pumps
- Implantable Loop Recorders
- Cochlear Implants
- Others
- By Country:
- Central Africa
- South Africa
- North Africa
- Company Profiles
- Cochlear Limited*
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments
- Boston Scientific Corporation
- Medtronic Plc.
- LivaNova Plc.
- Abbott Laboratories
- Sonova Holding AG
- William Demant holding A/S
- Nurotron Biotechnology Co. Ltd.
- Med-EL
“*” marked represents similar segmentation in other categories in the respective section.
